当前位置:首页 - 行情中心 - 赛托生物(300583) - 财务分析 - 现金流量表

赛托生物

(300583)

  

流通市值:26.10亿  总市值:26.60亿
流通股本:1.86亿   总股本:1.90亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金472,826,121.15328,861,563.01133,668,649.63822,928,510.35
  收到的税费返还6,008,155.22,952,789.18711,754.212,509,418.64
  收到其他与经营活动有关的现金74,502,568.3268,114,536.950,821,607.4843,206,302.24
  经营活动现金流入小计553,336,844.67399,928,889.09185,202,011.31878,644,231.23
  购买商品、接受劳务支付的现金280,228,955.55188,443,992.38112,102,535.42350,267,677.45
  支付给职工以及为职工支付的现金83,664,413.5556,656,372.0726,847,411.16133,692,077.12
  支付的各项税费23,869,256.7414,412,460.344,897,590.9856,655,247.43
  支付其他与经营活动有关的现金87,764,996.0177,734,441.5851,625,688.51143,569,639.95
  经营活动现金流出小计475,527,621.85337,247,266.37195,473,226.07684,184,641.95
  经营活动产生的现金流量净额77,809,222.8262,681,622.72-10,271,214.76194,459,589.28
二、投资活动产生的现金流量:
  收回投资收到的现金---3,000,000
  取得投资收益收到的现金4,130,021.224,130,021.224,130,021.22-
  处置固定资产、无形资产和其他长期资产收回的现金净额25,6207,500-245,100
  处置子公司及其他营业单位收到的现金净额---0
  收到的其他与投资活动有关的现金6,366,953.59--5,711,000
  投资活动现金流入小计10,522,594.814,137,521.224,130,021.228,956,100
  购建固定资产、无形资产和其他长期资产支付的现金34,956,932.9824,210,984.8215,219,229.7165,525,541.66
  投资支付的现金3,000,000---
  支付其他与投资活动有关的现金---744,785.48
  投资活动现金流出小计37,956,932.9824,210,984.8215,219,229.7166,270,327.14
  投资活动产生的现金流量净额-27,434,338.17-20,073,463.6-11,089,208.49-57,314,227.14
三、筹资活动产生的现金流量:
  取得借款收到的现金455,240,232.3415,240,232.3285,240,232.31,062,903,756.01
  收到其他与筹资活动有关的现金35,214,04035,770,95036,000,00048,500,000
  筹资活动现金流入小计490,454,272.3451,011,182.3321,240,232.31,111,403,756.01
  偿还债务支付的现金464,940,712.77401,240,120.45270,340,890.961,079,668,280.42
  分配股利、利润或偿付利息支付的现金22,661,868.7116,024,842.687,630,857.18112,853,418.76
  支付其他与筹资活动有关的现金24,425,250.2622,550,592.8619,855,343.7281,918,788.57
  筹资活动现金流出小计512,027,831.74439,815,555.99297,827,091.861,274,440,487.75
  筹资活动产生的现金流量净额-21,573,559.4411,195,626.3123,413,140.44-163,036,731.74
四、汇率变动对现金及现金等价物的影响-1,001,376.16-934,046.34-2,486,213.771,247,586.11
五、现金及现金等价物净增加额27,799,949.0552,869,739.09-433,496.58-24,643,783.49
  加:期初现金及现金等价物余额155,489,721.02155,489,721.02174,140,853.47180,133,504.51
  期末现金及现金等价物余额183,289,670.07208,359,460.11173,707,356.89155,489,721.02
补充资料:
  净利润--59,836,360.14--101,328,265.58
  资产减值准备-27,993,162.86-74,607,095.35
  固定资产和投资性房地产折旧-79,148,062.53-162,371,027.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-79,148,062.53-162,371,027.91
  无形资产摊销-3,561,673.36-7,665,708.94
  长期待摊费用摊销-785,937.33-514,644.6
  处置固定资产、无形资产和其他长期资产的损失-162,577.53--63,568.85
  固定资产报废损失-517,806.54-24,012.12
  财务费用-16,440,407.35-30,979,212.2
  投资损失--4,091,379.24--13,056,536.28
  递延所得税-3,638,470.44--5,034,295.27
  其中:递延所得税资产减少-3,732,765.02--4,933,156.51
    递延所得税负债增加--94,294.58--101,138.76
  存货的减少-106,271,263.38-4,768,197.3
  经营性应收项目的减少--77,640,828.4--23,628,677.9
  经营性应付项目的增加--33,280,121.09-52,031,264.14
  现金的期末余额-208,359,460.11-155,489,721.02
  减:现金的期初余额-155,489,721.02-180,133,504.51
  现金及现金等价物的净增加额-52,869,739.09--24,643,783.49
公告日期2025-10-292025-08-262025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑